Cardionet Inc: (NASD: BEAT)
$2.77
-0.06 (-2.12%)
Volume 36,688
May 17 04:00 PM ET
Zacks Rank: NA 
| |
Overview Quote
Stock Activity
| Day Low - High | 2.75 - 2.92 |
| 52wk Low - High | 1.84 - 3.00 |
| Previous Close | 2.83 |
| Avg. Volume | 69,139 |
| Industry | MED PRODUCTS |
| Market Cap | 69.85 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.44 |
| PE (Forward) | 0.00 |
| Current Year Est. | 0.00 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
|
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
175 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | NA |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-07-2013 |
| EPS Last Year | -0.21 |
| Expected Earnings Growth | NA |
Company Description
CARDIONET INC is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as the CardioNet System.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| CONCEPTUS INC | CPTS | 30.92 | |
|
| ATRICURE INC | ATRC | 9.07 | |
|
| CYTOSORBENTS CP | CTSO | 0.12 | |
|
| INVIVO THERAPT | NVIV | 2.89 | |
|
| TRANS1 INC | TSON | 1.70 | |
|
| ABAXIS INC | ABAX | 45.35 | |
|
| ADVAXIS INC | ADXS | 0.05 | |
|
| ALERE INC | ALR | 26.30 | |
|
| BAXTER INTL | BAX | 72.94 | |
|
| BIO-RAD LABS -A | BIO | 116.02 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Financials
| EPS TTM | -0.21 |
| Sales | 111 |
| Net Income | -11 |
| Price/Earnings | NA |
| Price/Book | 1.02 |
| Price/Cash Flow | 25.85 |
| Price/Sales | 0.60 |
News
BEAT, IRDM Are Seasonally Ripe To Go Up In the Next Five Weeks - M2
May 1, 2013
CardioNet announces name change to BioTelemetry - Datamonitor
May 1, 2013
CardioNet Q1 net loss decreases - Datamonitor
Apr 27, 2013
CardioNet Board Approves New Business Structure to Support Growth Strategy - Close-Up Media
Apr 25, 2013
CardioNet Modifies Business Structure - Close-Up Media
Apr 25, 2013
CardioNet Reports First Quarter 2013 Financial Results - Close-Up Media
Apr 25, 2013
CardioNet, Inc.Corporate Event Announcement Notice - Wall Street Horizon
Apr 23, 2013
CardioNet Trims Loss in Q1 - TheMotleyFool
Apr 22, 2013
Broker Recommendations
| Current ABR | NA |
| ABR (Last Week) | NA |
| # of recs in ABR | NA |
| Average Target Price | NA |
| Industry Rank by ABR | 175 out of 265 |
| Rank in Industry | NA |
